Parkinson’s Disease – BHV8000-301

A study to determine if BHV-8000 is efficacious, safe and tolerable in adults diagnosed with early Parkinson’s disease.

Key Inclusion Criteria:

• Male or female participants 40 to 85 years of age, inclusive, at the time of informed consent.
• Meet the diagnostic criteria for “Probable PD” as assessed on the Movement Disorder Society (MDS) Clinical Diagnostic Criteria for PD as assessed by the Investigator.
• Have a clinician-documented diagnosis of idiopathic PD with an onset within 2 years of the Screening Visit

Complete the form and our team will reach out soon to help determine your eligibility.